Renovascular Hypertension

Chapter

References

  1. 1.
    Kalra PA, Guo H, Kausz AT, et al. Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization, and prognosis. Kidney Int. 2005;68(1):293–301.CrossRefPubMedGoogle Scholar
  2. 2.
    Gray BH, Olin JW, Childs MB, Sullivan TM, Bacharach JM. Clinical benefit of renal artery angioplasty with stenting for the control of recurrent and refractory congestive heart failure. Vasc Med. 2002;7(4):275–9.CrossRefPubMedGoogle Scholar
  3. 3.
    Zeller T, Muller C, Frank U, et al. Survival after stenting of severe atherosclerotic ostial renal artery stenoses. J Endovasc Ther. 2003;10(3):539–45.PubMedGoogle Scholar
  4. 4.
    Harding MB, Smith LR, Himmelstein SI, et al. Renal artery stenosis: prevalence and associated risk factors in patients undergoing routine cardiac catheterization. J Am Soc Nephrol. 1992;2(11):1608–16.PubMedGoogle Scholar
  5. 5.
    Conlon PJ, Little MA, Pieper K, Mark DB. Severity of renal vascular disease predicts mortality in patients undergoing coronary angiography. Kidney Int. 2001;60(4):1490–7.CrossRefPubMedGoogle Scholar
  6. 6.
    Missouris CG, Buckenham T, Cappuccio FP, MacGregor GA. Renal artery stenosis: a common and important problem in patients with peripheral vascular disease. Am J Med. 1994;96(1):10–4.CrossRefPubMedGoogle Scholar
  7. 7.
    Derkx FH, Schalekamp MA. Renal artery stenosis and hypertension. Lancet. 1994;344(8917):237–9.CrossRefPubMedGoogle Scholar
  8. 8.
    Guo H, Kalra PA, Gilbertson DT, et al. Atherosclerotic renovascular disease in older US patients starting dialysis, 1996 to 2001. Circulation. 2007;115(1):50–8.CrossRefPubMedGoogle Scholar
  9. 9.
    van den Dool SW, Wasser MN, de Fijter JW, Hoekstra J, van der Geest RJ. Functional renal volume: quantitative analysis at gadolinium-enhanced MR angiography—feasibility study in healthy potential kidney donors. Radiology. 2005;236(1):189–95.CrossRefPubMedGoogle Scholar
  10. 10.
    Bakker J, Olree M, Kaatee R, et al. Renal volume measurements: accuracy and repeatability of US compared with that of MR imaging. Radiology. 1999;211(3):623–8.CrossRefPubMedGoogle Scholar
  11. 11.
    Coulam CH, Bouley DM, Sommer FG. Measurement of renal volumes with contrast-enhanced MRI. J Magn Reson Imaging. 2002;15(2):174–9.CrossRefPubMedGoogle Scholar
  12. 12.
    Grobner T. Gadolinium—a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant. 2006;21(4):1104–8.CrossRefPubMedGoogle Scholar
  13. 13.
    Marckmann P, Skov L, Rossen K, Heaf JG, Thomsen HS. Case-control study of gadodiamide-related nephrogenic systemic fibrosis. Nephrol Dial Transplant. 2007;22(11):3174–8.CrossRefPubMedGoogle Scholar
  14. 14.
    Commission on Human Medicines. Nephrogenic systemic fibrosis (NSF) with gadolinium-containing magnetic resonance imaging (MRI) contrast agents: update. Medicines and Healthcare Products Regulatory Agency Web site. http://www.mhra.gov.uk/Safetyinformation/Safetywarningsalertsandrecalls/Safetywarningsandmessagesformedicines/CON2030229. Accessed 1 Feb 2010. 26-7-0007. Ref Type: Internet Communication.
  15. 15.
    Mounier-Vehier C, Cocheteux B, Haulon S, et al. Changes in renal blood flow reserve after angioplasty of renal artery stenosis in hypertensive patients. Kidney Int. 2004;65(1):245–50.CrossRefPubMedGoogle Scholar
  16. 16.
    Vasbinder GB, Nelemans PJ, Kessels AG, Kroon AA, de Leeuw PW, van Engelshoven JM. Diagnostic tests for renal artery stenosis in patients suspected of having renovascular hypertension: a meta-analysis. Ann Intern Med. 2001;135(6):401–11.CrossRefPubMedGoogle Scholar
  17. 17.
    Wheatley K, Ives N, Gray R, et al. Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med. 2009;361(20):1953–62.CrossRefPubMedGoogle Scholar
  18. 18.
    Cheung CM, Patel A, Shaheen N, et al. The effects of statins on the progression of atherosclerotic renovascular disease. Nephron Clin Pract. 2007;107(2):c35–42.CrossRefPubMedGoogle Scholar
  19. 19.
    Treatment of adults and children with renal failure: standards and audit measures. 3rd ed. London: RCP London and the Renal Ass, 2002. 2007. Ref Type: Generic.Google Scholar
  20. 20.
    Shekelle PG, Rich MW, Morton SC, et al. Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials. J Am Coll Cardiol. 2003;41(9):1529–38.CrossRefPubMedGoogle Scholar
  21. 21.
    Kalra PA, Guo H, Gilbertson DT, et al. Atherosclerotic renovascular disease in the United States. Kidney Int. 2010;77(1):37–43.CrossRefPubMedGoogle Scholar
  22. 22.
    Bloch MJ, Trost DW, Pickering TG, Sos TA, August P. Prevention of recurrent pulmonary edema in patients with bilateral renovascular disease through renal artery stent placement. Am J Hypertens. 1999;12(1 Pt 1):1–7.CrossRefPubMedGoogle Scholar
  23. 23.
    Pickering TG, Herman L, Devereux RB, et al. Recurrent pulmonary oedema in hypertension due to bilateral renal artery stenosis: treatment by angioplasty or surgical revascularisation. Lancet. 1988;2(8610):551–2.CrossRefPubMedGoogle Scholar
  24. 24.
    Messina LM, Zelenock GB, Yao KA, Stanley JC. Renal revascularization for recurrent pulmonary edema in patients with poorly controlled hypertension and renal insufficiency: a distinct subgroup of patients with arteriosclerotic renal artery occlusive disease. J Vasc Surg. 1992;15(1):73–80.CrossRefPubMedGoogle Scholar
  25. 25.
    Harden PN, MacLeod MJ, Rodger RS, et al. Effect of renal-artery stenting on progression of renovascular renal failure. Lancet. 1997;349(9059):1133–6.CrossRefPubMedGoogle Scholar
  26. 26.
    Scoble JE. Atherosclerotic nephropathy. Kidney Int Suppl. 1999;71:S106–9.CrossRefPubMedGoogle Scholar
  27. 27.
    Goldsmith DJ, Reidy J, Scoble J. Renal arterial intervention and angiotensin blockade in atherosclerotic nephropathy. Am J Kidney Dis. 2000;36(4):837–43.CrossRefPubMedGoogle Scholar
  28. 28.
    Cooper CJ, Murphy TP, Cutlip DE, et al. Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med. 2014;370(1):13–22.Google Scholar
  29. 29.
    Van de Ven PJ, Kaatee R, Beutler JJ, et al. Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: a randomised trial. Lancet. 1999;353(9149):282–6.CrossRefPubMedGoogle Scholar
  30. 30.
    Iannone LA, Underwood PL, Nath A, Tannenbaum MA, Ghali MG, Clevenger LD. Effect of primary balloon expandable renal artery stents on long-term patency, renal function, and blood pressure in hypertensive and renal insufficient patients with renal artery stenosis. Catheter Cardiovasc Diagn. 1996;37(3):243–50.CrossRefGoogle Scholar
  31. 31.
    Zeller T, Frank U, Muller C, et al. Predictors of improved renal function after percutaneous stent-supported angioplasty of severe atherosclerotic ostial renal artery stenosis. Circulation. 2003;108(18):2244–9.CrossRefPubMedGoogle Scholar
  32. 32.
    Alhadad A, Ahle M, Ivancev K, Gottsater A, Lindblad B. Percutaneous transluminal renal angioplasty (PTRA) and surgical revascularisation in renovascular disease—a retrospective comparison of results, complications, and mortality. Eur J Vasc Endovasc Surg. 2004;27(2):151–6.CrossRefPubMedGoogle Scholar
  33. 33.
    Granillo GA, van Dijk LC, McFadden EP, Serruys PW. Percutaneous radial intervention for complex bilateral renal artery stenosis using paclitaxel eluting stents. Catheter Cardiovasc Interv. 2005;64(1):23–7.CrossRefPubMedGoogle Scholar
  34. 34.
    Cooper CJ, Haller ST, Colyer W, et al. Embolic protection and platelet inhibition during renal artery stenting. Circulation. 2008;117(21):2752–60.CrossRefPubMedGoogle Scholar
  35. 35.
    Holden A, Hill A. Renal angioplasty and stenting with distal protection of the main renal artery in ischemic nephropathy: early experience. J Vasc Surg. 2003;38(5):962–8.CrossRefPubMedGoogle Scholar
  36. 36.
    Tan J, Filobbos R, Raghunathan G, et al. Efficacy of renal artery angioplasty and stenting in a solitary functioning kidney. Nephrol Dial Transplant. 2007;22(7):1916–9.CrossRefPubMedGoogle Scholar
  37. 37.
    Steinbach F, Novick AC, Campbell S, Dykstra D. Long-term survival after surgical revascularization for atherosclerotic renal artery disease. J Urol. 1997;158(1):38–41.CrossRefPubMedGoogle Scholar
  38. 38.
    Edwards MS, Craven TE, Burke GL, Dean RH, Hansen KJ. Renovascular disease and the risk of adverse coronary events in the elderly: a prospective, population-based study. Arch Intern Med. 2005;165(2):207–13.CrossRefPubMedGoogle Scholar
  39. 39.
    Wright JR, Shurrab AE, Cheung C, et al. A prospective study of the determinants of renal functional outcome and mortality in atherosclerotic renovascular disease. Am J Kidney Dis. 2002;39(6):1153–61.CrossRefPubMedGoogle Scholar
  40. 40.
    Conlon PJ, Athirakul K, Kovalik E, et al. Survival in renal vascular disease. J Am Soc Nephrol. 1998;9(2):252–6.PubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Renal MedicineSalford Royal Hospitals NHS Foundation Trust and University of ManchesterManchesterUK

Personalised recommendations